The Critical Investor

Recent Articles

FDA Approves New Skin Resurfacing Device 05/26/2022

Apyx Medical Corp. shares traded 50% higher after the company reported it received U.S. FDA 510(k) clearance for its Renuvion Dermal Handpiece for use in specific cosmetic dermal resurfacing procedures.

Due to permission requirements, not all quotes are shown.